July 13, 2020 11:05 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Rajasthan crisis: Sachin Pilot, loyalists in Delhi to meet Congress High Command | New Delhi/IBNS: India's single-day spike in coronavirus cases reached a record high with 28,637 fresh infections reported in the last 24 hours, the Ministry of Health informed on Sunday. | Amitabh Bachchan, COVID-19 positive, is stable with mild symptoms, says hospital | Aadhaar, test results must for COVID-19 drug procurement in Maharashtra | Abhishek Bachchan also tests positive for Covid-19 along with father Amitabh Bachchan

WHO discontinues trials of hydroxychloroquine, lopinavir/ritonavir in COVID-19 treatment

Geneva/IBNS: The World Health Organisation (WHO) has informed that it is discontinuing the use of hydroxychloroquine and lopinavir/ritonavir arms in COVID-19 treatment for hospitalised patients as a part of its Solidarity Trial, stating the drugs had little effect on reducing the mortality rate.

WHO set to resume hydroxychloroquine trial to fight Coronavirus outbreak

Geneva: Investigations will continue into the effectiveness of hydroxychloroquine in treating COVID-19,  , WHO chief Tedros Adhanom Ghebreyesus  said.

No evidence of benefit for chloroquine and hydroxychloroquine in COVID-19 patients, urgent randomised trials are needed: Study 

London: A large observational study suggests that treatment with the antimalarial drug chloroquine or its analogue hydroxychloroquine (taken with or without the antibiotics azithromycin or clarithromycin) offers no benefit for patients with COVID-19. The study analysed data from nearly 15,000 patients with COVID-19 receiving a combination of any of the four drug regimens and 81,000 controls.

No evidence of benefit for chloroquine and hydroxychloroquine in COVID-19 patients: Study

New York/IBNS: A large observational study suggests that treatment with the antimalarial drug chloroquine or its analogue hydroxychloroquine (taken with or without the antibiotics azithromycin or clarithromycin) offers no benefit for patients with COVID-19.

Donald Trump says taking hydroxychloroquine as preventive measure against COVID-19

Washington/UNI: US President Donald Trump has said that he is taking hydroxychloroquine as a preventive measure against the novel coronavirus disease, even though it is not yet a proven treatment.

Hydroxychloroquine: First large study does not support routine use in COVID-19 patients

New York/IBNS: A study of nearly 1,400 patients with moderate to severe COVID-19 disease at a single New York hospital found that patients who received the drug fared no better than patients who did not receive the drug.

Supreme Court bench admits PIL on use of Hydroxychloroquine for Covid-19 patients

New Delhi/Columbus, Ohio/IBNS: The Supreme Court has admitted a Public Interest Litigation (PIL) filed by US-based Indian American doctor and patients' rights activist Kunal Saha on the use of Hydroxychloroquine (HCQ) and Azithromycin (AZM) in acutely ill COVID-19 patients.

Hydroxychloroquine fails to reduce COVID-19 death rates- Medical Study

Washington/Sputnik/UNI: The use of hydroxychloroquine with and without other medications has failed to reduce death rates from the coronavirus (COVID-19) and can actually cause fatalities, a study funded by the National Institutes of Health (NIH) and the University of Virginia said.

ICMR says HCQ not to be used as COVID-19 cure

New Delhi/IBNS: The Indian Council of Medical Research(ICMR) on Saturday recommended hydroxychloroquine or HCQ  as prophylaxis to prevent coronavirus infection instead of a treatment for COVID-19, said media reports.